A bill requiring the Board of Pharmacy to report to the Legislature regarding monitoring and use of opioids has passed both chambers of the South Dakota Legislature and now heads to Gov. Dennis Daugaard for his signature.

Senate Bill 4, which came out of the summer Interim Substance Abuse Prevention Study Committee, requires the board to report to the Senate and House standing committees on health and human services each January on the monitoring and use of prescription opioids. The report will include the number of opioid prescriptions from the prior three years and an update to any changes or advances made to the prescription drug monitoring program.

The bill is scheduled to sunset on June 30, 2022.